Kaiser Permanente新生儿早发型脓毒症风险计算器(SRC)与NICE指南CG149在胎龄≥34周早发型脓毒症患儿管理推荐中的比较
该回顾性多中心研究比较了Kaiser Permanente新生儿早发型脓毒症风险计算器(SRC)与NICE指南CG149在胎龄≥34周、经血或脑脊液培养确诊早发型脓毒症(<72小时)的70例患儿中的管理推荐。通过回顾性虚拟应用两种工具,主要结局为出生4小时内推荐抗生素的患儿数。结果显示,NICE推荐39例(55.7%),SRC推荐27例(38.6%);NICE额外推荐的12例中仅1例在4小时后出现短暂轻微症状,其余保持健康。81%的患儿因临床症状而非仅风险因素接受治疗,仅1例出生时即病情危重并死亡。结论认为两种工具在4小时内识别EOS的能力均较差,但NICE在识别无症状病例方面优于SRC。
要点
- 在70例确诊早发型脓毒症(<72小时)的胎龄≥34周患儿中,NICE指南推荐出生4小时内使用抗生素39例(55.7%),SRC推荐27例(38.6%)。
- NICE额外推荐而SRC未推荐的12例患儿均保持健康,仅1例在4小时后出现短暂轻微症状。
- 81%的早发型脓毒症患儿因临床症状而非仅风险因素接受治疗,大多数在出生24小时内出现症状。
- 仅1例出生时即病情危重的患儿死亡。
- 使用SRC的抗生素管理项目应加强对目前按NICE指南治疗的患儿的观察。
适用人群与场景
- 胎龄≥34周、经血或脑脊液培养确诊早发型脓毒症(<72小时)的婴儿。
- 研究场景为英格兰西南部和威尔士的五家产科服务机构。
研究设计与关键结果
- 研究设计为回顾性多中心研究,纳入70例胎龄≥34周、经血或脑脊液培养确诊早发型脓毒症(<72小时)的婴儿。
- 胎龄≥34周早发型脓毒症发病率为0.5/1000活产。
- 出生4小时内推荐抗生素:NICE指南39例(55.7%),SRC 27例(38.6%)。
- NICE推荐而SRC未推荐的12例患儿均保持健康,仅1例在4小时后出现短暂轻微症状。
- 另有4例婴儿在4小时内接受了NICE和SRC指南之外的抗生素治疗。
- 剩余27例(38.6%)在4小时后出现症状时接受抗生素治疗。
- 仅1例出生时即病情危重的婴儿死亡。
- 所有早发型脓毒症婴儿中81%因临床原因而非仅风险因素接受治疗。
证据类型、等级与局限
- 证据类型:回顾性多中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在胎龄≥34周婴儿中,NICE指南在识别无症状早发型脓毒症方面优于SRC,但两种工具在出生4小时内识别EOS的能力均较差。
- 使用SRC的抗生素管理项目应加强对目前按NICE指南治疗的婴儿的观察。
指南或共识出处
- NICE guideline CG149
- Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC)
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To compare the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC) with National Institute for Health and Care Excellence (NICE) guideline CG149 in infants ≥34 weeks' gestation who developed early-onset sepsis (EOS).
DESIGN: Retrospective multicentre study.
SETTING: Five maternity services in South West of England and Wales.
PATIENTS: 70 infants with EOS (<72 hours) confirmed on blood or cerebrospinal fluid culture.
METHODS: Retrospective virtual application of NICE and SRC through review of maternal and neonatal notes.
MAIN OUTCOME MEASURE: The number of infants recommended antibiotics by 4 hours of birth.
RESULTS: The incidence of EOS ≥34 weeks was 0.5/1000 live births. Within 4 hours of birth, antibiotics were recommended for 39 infants (55.7%) with NICE, compared with 27 (38.6%) with SRC. The 12 infants advised early treatment by NICE but not SRC remained well, only one showing transient mild symptoms after 4 hours. Another four babies received antibiotics by 4 hours outside NICE and SRC guidance. The remaining 27 infants (38.6%) received antibiotics when symptomatic after 4 hours. Only one infant who was unwell from birth, died. Eighty-one per cent of all EOS infants were treated for clinical reasons rather than for risk factors alone.
CONCLUSION: While both tools were poor in identifying EOS within 4 hours, NICE was superior to SRC in identifying asymptomatic cases. Currently, four out of five EOS have symptoms at first identification, the majority of whom present within 24 hours of birth. Antibiotic stewardship programmes using SRC should include enhanced observation for infants currently treated within NICE guidance.
参考来源
- Morris R, Jones S, Banerjee S, et al. Comparison of the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC) with NICE guideline CG149 in infants ≥34 weeks' gestation who developed early-onset sepsis. Arch Dis Child Fetal Neonatal Ed. 2020. PMID: 32170032. doi:10.1136/archdischild-2019-317165
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。